Your browser doesn't support javascript.
loading
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Crugnola, Monica; Castagnetti, Fausto; Breccia, Massimo; Ferrero, Dario; Trawinska, Malgorzata Monika; Abruzzese, Elisabetta; Annunziata, Mario; Stagno, Fabio; Tiribelli, Mario; Binotto, Gianni; Bonifacio, Massimiliano; Fava, Carmen; Iurlo, Alessandra; Bucelli, Cristina; Mansueto, Giovanna; Gozzini, Antonella; Falzetti, Franca; Montefusco, Enrico; Crisà, Elena; Gugliotta, Gabriele; Russo, Sabina; Cedrone, Michele; RussoRossi, Antonella; Pregno, Patrizia; Isidori, Alessandro; Mauro, Endri; Atelda, Romano; Giglio, Gianfranco; Celesti, Francesca; Sorà, Federica; Storti, Sergio; D'Addosio, Adam; Galimberti, Sara; Orlandi, Ester; Calistri, Elisabetta; Bocchia, Monica; Cavazzini, Francesco; Rege Cambrin, Giovanna; Orofino, Nicola; Luciano, Luigiana; Sgherza, Nicola; Rosti, Gianantonio; Latagliata, Roberto; Capodanno, Isabella.
Afiliação
  • Crugnola M; Hematology and BMT Center, "Azienda Ospedaliero-Universitaria di Parma," Department Medicine and Surgery, University of Parma, Parma, Italy. mcrugnola@ao.pr.it.
  • Castagnetti F; Institute of Hematology "L and A Seragnoli," Department of Experimental Hematology, Diagnostic and Speciality Medicine, S.Orsola Malpighi, University Hospital Bologna, Bologna, Italy.
  • Breccia M; Department of Cellular Biotechnologies and Hematology, University "La Sapienza" of Rome, Rome, Italy.
  • Ferrero D; Hematology Unit, University of Turin, Turin, Italy.
  • Trawinska MM; Hematology, S. Eugenio Hospital, Tor Vergata, University of Rome, Rome, Italy.
  • Abruzzese E; Hematology, S. Eugenio Hospital, Tor Vergata, University of Rome, Rome, Italy.
  • Annunziata M; Hematology, Ospedale Cardarelli, Naples, Italy.
  • Stagno F; Hematology, Ospedale Ferrarotto, Catania, Italy.
  • Tiribelli M; Department of Medical Area University of Udine, Udine, Italy.
  • Binotto G; Hematology Unit, University of Padova, Padova, Italy.
  • Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Fava C; Division of Hematology and Internal Medicine, University of Turin "San Luigi Gonzaga", Turin, Italy.
  • Iurlo A; Oncohematology Division, IRCCS Ca'Granda-Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Bucelli C; Oncohematology Division, IRCCS Ca'Granda-Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Mansueto G; Department of Onco-Hematology, IRCS-CROB, Rionero in Volture, Italy.
  • Gozzini A; Hematology, AOU Careggi, University of Florence, Florence, Italy.
  • Falzetti F; Division of Hematology and Clinical Immunology, Department of Medicine, University of Perugia, Perugia, Italy.
  • Montefusco E; Hematology Unit Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy.
  • Crisà E; Haematology Division Università degli Studi di Torino, Turin, Italy.
  • Gugliotta G; Institute of Hematology "L and A Seragnoli," Department of Experimental Hematology, Diagnostic and Speciality Medicine, S.Orsola Malpighi, University Hospital Bologna, Bologna, Italy.
  • Russo S; Hematology University, Messina, Italy.
  • Cedrone M; Hematology Unit, San Giovanni Hospital, Rome, Italy.
  • RussoRossi A; Hematology and Transplantation Unit, University of Bari, Bari, Italy.
  • Pregno P; Hematology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.
  • Isidori A; Hematology Unit, Pesaro Hospital Italy, Urbino, Italy.
  • Mauro E; Department of Internal Medicine, Pordenone General Hospital, Pordenone, Italy.
  • Atelda R; Department of Cellular Biotechnologies and Hematology, University "La Sapienza" of Rome, Rome, Italy.
  • Giglio G; Hematology Unit, Ospedale Civile, Campobasso, Italy.
  • Celesti F; Hematology Unit, Ospedale Belcolle, Viterbo, Italy.
  • Sorà F; Institute of Hematology, Università Cattolica SacroCuore, Rome, Italy.
  • Storti S; Oncohematology Unit, Università Cattolica Giovanni Paolo II, Rome, Italy.
  • D'Addosio A; Immunohematology and Transfusional Medicine Division, S. Pietro Fatebenefratelli Hospital, Rome, Italy.
  • Galimberti S; Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa Italy, Pisa, Italy.
  • Orlandi E; Hematology Unit, IRCCS Policlinico San Matteo, Pavia, Italy.
  • Calistri E; Hematology Unit, Treviso Hospital, Treviso, Italy.
  • Bocchia M; Hematology Unit, Azienda Ospedaliero Universitaria Senese and University of Siena, Siena, Italy.
  • Cavazzini F; Hematology Unit, University of Ferrara, Ferrara, Italy.
  • Rege Cambrin G; Division of Hematology and Internal Medicine University of Turin, "San Luigi Gonzaga" University Hospital, Orbassano, Italy.
  • Orofino N; Oncohematology Division, IRCCS Ca'Granda-Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Luciano L; Hematology Unit "Federico II Hospital", University of Naples, Naples, Italy.
  • Sgherza N; Hematology Unit, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
  • Rosti G; Institute of Hematology "L and A Seragnoli," Department of Experimental Hematology, Diagnostic and Speciality Medicine, S.Orsola Malpighi, University Hospital Bologna, Bologna, Italy.
  • Latagliata R; Department of Cellular Biotechnologies and Hematology, University "La Sapienza" of Rome, Rome, Italy.
  • Capodanno I; Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
Ann Hematol ; 98(10): 2329-2338, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31392461
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article